Two arrested, spurious medicines worth ₹29.72 lakh seized

The Commissioner’s Task Force (South-West) and Malakpet police along with the Drugs Inspector, Malakpet zone, arrested two persons for allegedly selling spurious medicine and without a valid licence.

Pocala Ramesh, 43, of Karmanghat and Beerely Raghava Reddy, 55, of Peddaamberpet, ventured into the business after losses in real-estate business, police said.

Through the relative of Ramesh, Purnachander, who was once arrested for similar violations, they came up with a plan to carry out the illegal business of drug supply. They got in touch with one Nedeem of Uttar Pradesh and Arun Choudary of Delhi, procured medicine and got them transported through courier, concealed in garment parcels.

The police seized several boxes of syrups and tablets worth about ₹29.72 lakh from them. Police are yet to arrest the remaining accused persons – Purnachander, Laxman, Nadeem and Arun Choudary.

Related Posts

  • Pharma
  • May 10, 2025
  • 93 views
Pharma sector continues to thrive, driven by price-led expansion

The Indian pharmaceutical market continued rising in April 2025, achieving a strong annual growth of 7.8%, with total sales reaching a remarkable Rs 19,711 crore. According to a report by…

  • Pharma
  • May 10, 2025
  • 87 views
TPG to acquire 35% stake in SCHOTT Poonawalla from SII

Mumbai:  SCHOTT Pharma has announced that TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in its joint venture SCHOTT Poonawalla…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pharma sector continues to thrive, driven by price-led expansion

Pharma sector continues to thrive, driven by price-led expansion

TPG to acquire 35% stake in SCHOTT Poonawalla from SII

TPG to acquire 35% stake in SCHOTT Poonawalla from SII

Indian pharma industry showed impressive growth in April 2025, by price led expansion: Report

Indian pharma industry showed impressive growth in April 2025, by price led expansion: Report

Diabetes drug shows promise for treating prostate cancer

Diabetes drug shows promise for treating prostate cancer